{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-25-000113","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.628643+00:00","generated_at":"2026-05-17T02:12:50.272553+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Maravai LifeSciences reduces board from 11 to 8; three directors resign","bullets":["Benjamin Daverman, Jessica Hopfield, and Murali Prahalad resigned from the Board effective Oct 21, 2025.","Board size reduced from 11 to 8 directors effective Oct 27, 2025; resignations were not due to any disagreement.","R. Andrew Eckert named chair of Nominating, Governance and Risk Committee and member of Audit Committee.","Gregory T. Lucier appointed to Nominating, Governance and Risk Committee; unvested RSUs for departing directors accelerated."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-25-000113","json":"https://secwatch.observer/filing/0001823239-25-000113.json","markdown":"https://secwatch.observer/filing/0001823239-25-000113.md","text":"https://secwatch.observer/filing/0001823239-25-000113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/0001823239-25-000113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/mrvi-20251021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:12:50.272553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}